AKBA

Akebia Therapeut

0.9747

-0.0086-0.87%

Closed19:30 09/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.9880/0.9833

TODAY RANGE0.9471-0.9961

VOL8.35M

MARKET CAP270.10M

52 WEEK RANGE0.8140-3.220

AVG VOL (3M)6.25M

% TURNOVER3.01%

TURNOVER0

P/E (TTM)-8.7811

% RANGE4.98%

EPS(TTM)-0.1110

P/E(FORWARD)-6.4125

P/B10.58

BVPS0.0921

DIVIDEND--

P/S1.095

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP253.64M

SHARES OUTSTANDING277.11M

NEXT EARNINGS11/09-11/13

FREE FLOAT260.23M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

TipRanks·3d ago
Akebia’s Vadadustat Trial Nears Data Readout, Raising Stakes in Dialysis Anemia Market
TipRanks·08/17 12:21
Piper Sandler Reaffirms Their Buy Rating on Akebia Therapeutics (AKBA)
Dow Jones·08/08 00:30
Akebia Therapeutics Cut to Market Perform From Outperform by Leerink Partners
Dow Jones·08/08 00:30
Akebia Therapeutics Price Target Announced at $1.00/Share by Leerink Partners
TipRanks·08/07 10:21
Akebia downgraded to Market Perform from Outperform at Leerink
TipRanks·08/06 10:30
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Envista Holdings (NVST) and Akebia Therapeutics (AKBA)
TipRanks·08/06 10:10
Akebia Therapeutics: Strengthening Vafseo Traction and De-Risked VOICE Trial Outcomes Support Buy Rating
Dow Jones·08/05 20:05
Press Release: Akebia Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Dow Jones·08/05 20:05
*Akebia Therapeutics 2Q Loss $8.91M >AKBA
Dow Jones·08/05 20:05
*Akebia Therapeutics 2Q Loss/Shr 3c >AKBA
Dow Jones·08/05 20:05
*Akebia Therapeutics 2Q Rev $49.1M >AKBA
Seeking Alpha·08/05 14:00
Here are the major earnings after the close Wednesday
NASDAQ·08/03 15:34
Akebia Initiates Phase 2 Trial For Ebribafusp In Kidney Diseases; Initial Data In '27
Seeking Alpha·07/14 11:30
Akebia: Vafseo Gains Traction, But It's Still A Show-Me Story (Rating Downgrade)
TipRanks·07/04 13:01
Insider Shake-Up: GC, Akebia, Perion, Paychex, Arqit

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-1.45%

907.99

Biogen Inc

BIIB

-1.64%

220.83

AMGN

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-6.69%

0.1380

LLY

Celgene

CELG

0.00%

108.24

TXMD

Johnson & Johnson

JNJ

-1.15%

275.23

Abbvie Inc

ABBV

-1.44%

256.46

Zoetis Inc

ZTS

-0.63%

75.81

GILD

Novo-Nordisk A/S

NVO

-1.92%

46.60

Bristol-Myers Squibb Co

BMY

-1.87%

66.82

ALXN

Pfizer

PFE

-1.25%

28.45

SNY

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-1.90%

159.99

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.